Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1997-10-29
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0360-3016
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
671-2
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9336148-Androgen Antagonists,
pubmed-meshheading:9336148-Antineoplastic Agents, Hormonal,
pubmed-meshheading:9336148-Combined Modality Therapy,
pubmed-meshheading:9336148-Humans,
pubmed-meshheading:9336148-Lymphatic Metastasis,
pubmed-meshheading:9336148-Male,
pubmed-meshheading:9336148-Neoplasm Staging,
pubmed-meshheading:9336148-Prostatic Neoplasms
|
pubmed:year |
1997
|
pubmed:articleTitle |
Node-positive prostatic carcinoma.
|
pubmed:publicationType |
Editorial,
Comment
|